Sign in
4

Changes in Ownership

AGIOS PHARMACEUTICALS, INC. Filed Acc 0001439222-24-000046

Chief Legal Officer sold 2,642 shares at $32.57 ($86,050)

  • Chief Legal Officer acquired 7,834 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Burns James William · Chief Legal Officer

Table I: Non-derivative

4 lines
Date Transaction Shares Price Value Owned after D/I
2024-03-01 Exercise or conversion : show line 1 in the form 10b5-1 +3,834 35,811 D
2024-03-05 Sale : show line 2 in the form 10b5-1 −1,293 $32.57 $42,113 34,518 D
2024-03-01 Exercise or conversion : show line 3 in the form 10b5-1 +4,000 38,518 D
2024-03-05 Sale : show line 4 in the form 10b5-1 −1,349 $32.57 $43,937 37,169 D
Open-market sales · 2,642 sh · avg $32.57 · $86,050

Table II: Derivative

4 lines
Date Transaction Shares Owned after D/I
2024-03-01 Grant or award : show line 5 in the form 10b5-1 Restricted stock units +17,000 17,000 D
2024-03-01 Grant or award : show line 6 in the form 10b5-1 Stock options (right to buy) +60,000 60,000 D
2024-03-01 Exercise or conversion : show line 7 in the form 10b5-1 Restricted stock units −3,834 3,833 D
2024-03-01 Exercise or conversion : show line 8 in the form 10b5-1 Restricted stock units −4,000 8,000 D
Loading xslF345X05/wk-form4_1709672898.xml…